Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer

Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a destructive disease with a poor prognosis, low survival rate and high rate of metastasis. It comprises 15% of total breast cancers and is marked by deficiency of three important receptor expressions, i.e., progesterone, estrogen, and human epidermal growth f...

Full description

Bibliographic Details
Main Authors: Mahak Fatima, Afsana Sheikh, Mohammed A. S. Abourehab, Prashant Kesharwani
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Pharmaceutics
Subjects:
triple-negative breast cancer
drug-delivery system
polymeric nanoparticles
nanotechnology
immunotherapy
cancer-stem cells
Online Access:https://www.mdpi.com/1999-4923/14/11/2432

Internet

https://www.mdpi.com/1999-4923/14/11/2432

Similar Items